Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid na... Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology. Show more
Believes Now Is the Logical Time for Arbutus to Pursue a License and Collaboration Agreement With a Strategic Partner and Explore All Options for HBV Portfolio Urges Arbutus to Commit to No...
WARMINSTER, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
50% of patients who had baseline HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the IM-PROVE I Phase 2a clinical trial Overall, in Cohort A1, 25% of patients achieved...
WARMINSTER, Pa., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.335 | -9.46327683616 | 3.54 | 3.605 | 3.13 | 808968 | 3.36206752 | CS |
4 | -0.265 | -7.63688760807 | 3.47 | 3.79 | 3.13 | 787885 | 3.50021781 | CS |
12 | -0.755 | -19.0656565657 | 3.96 | 4.3491 | 3.13 | 840631 | 3.74911844 | CS |
26 | 0.205 | 6.83333333333 | 3 | 4.725 | 2.915 | 997994 | 3.81308085 | CS |
52 | 0.995 | 45.0226244344 | 2.21 | 4.725 | 2.199 | 1054622 | 3.30927301 | CS |
156 | -0.965 | -23.1414868106 | 4.17 | 4.725 | 1.69 | 1093080 | 2.91167976 | CS |
260 | 0.955 | 42.4444444444 | 2.25 | 9 | 0.88 | 2132944 | 3.71865873 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales